Why health care reform must tackle the escalating cost of medical technology
Technological innovation is deeply woven into the fabric of American culture, and is no less a basic feature of American health care. Medical technology saves lives and relieves suffering, and is enormously popular with the public, profitable for doctors, and a source of great wealth for industry. Yet its costs are rising at a dangerously unsustainable rate. The control of technology costs poses a terrible ethical and policy dilemma. How can we deny people what they may need to live and flourish? Yet is it not also harmful to let rising costs strangle our health care system, eventually harming everyone?
In Taming the Beloved Beast, esteemed medical ethicist Daniel Callahan confronts this dilemma head-on. He argues that we can't escape it by organizational changes alone. Nothing less than a fundamental transformation of our thinking about health care is needed to achieve lasting and economically sustainable reform. The technology bubble, he contends, is beginning to burst.
Callahan weighs the ethical arguments for and against limiting the use of medical technologies, and he argues that reining in health care costs requires us to change entrenched values about progress and technological innovation. Taming the Beloved Beast shows that the cost crisis is as great as that of the uninsured. Only a government-regulated universal health care system can offer the hope of managing technology and making it affordable for all.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Daniel Callahan is senior researcher and president emeritus at the Hastings Center, which he cofounded, and an elected member of the Institute of Medicine of the National Academy of Sciences. His many books include Medicine and the Market.
"Dan Callahan is one of the most important thinkers in health care today. Love him or hate him, you need to reckon with his ideas. Taming the Beloved Beast is a direct challenge to the central health care issue of our time--the capability and cost of medical care."--David Cutler, Harvard University
"An extraordinarily clear and important contribution. Callahan argues that many new medical technologies yield only very marginal benefits relative to their high costs for the majority of those who receive them. This book should be of interest to everyone who is involved in any way with health care policy and health reform issues."--Leonard M. Fleck, Michigan State University
"This is the only major book of which I am aware that places the escalating costs of medical technology at the center of the health care reform maelstrom. Callahan explains why we are facing a serious and urgent crisis in health care spending and why a cultural revolution is needed to bring about meaningful and sustainable change."--Alan B. Cohen, Boston University Health Policy Institute
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
EUR 0,63 für den Versand von USA nach Deutschland
Versandziele, Kosten & DauerAnbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Artikel-Nr. WP-9780691177991
Anzahl: 15 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Artikel-Nr. WP-9780691177991
Anzahl: 15 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2017. Reprint. Paperback. . . . . . Books ship from the US and Ireland. Artikel-Nr. V9780691177991
Anzahl: 15 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9780691177991_new
Anzahl: 15 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 280. Artikel-Nr. 409317481
Anzahl: 3 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. reprint edition. 280 pages. 9.50x6.00x0.75 inches. In Stock. Artikel-Nr. xi0691177996
Anzahl: 2 verfügbar